Schedule
1ST DAY
15th September 2022
2ND DAY
16th September 2022
REGISTRATION
8:15-9:00
TALKS BY EXPERTS - PART 1
(open for public)
9:00-10:45
COFFEE BREAK
(open for public)
10:45-11:15
TALK BY
EXPERTS - PART 2
(open for public)
11:15-12:15
LUNCH BREAK
12:15-13:45
Registration of participants at the auditorium at the Gertrud-Woker-Strasse 5.
Greeting by the organisers and partners.
Opening talk session about personalised medicine in pharma industry.
Coffee provided on-site.
Continuation of the talk series about considerations when opening a biotech startup and business pitching.
Lunch provided by Swiss Women in Chemistry (SWC) - closed for the case-challenge participants and SWC guests.
BREAKFAST & COFFEE
8:00-8:30
Provided at the accomodation.
WORK IN TEAMS
9:00-12:00
Teams work in separate seminar rooms on their solutions and finalize their presentations.
LUNCH BREAK
12:00-13:00
Organised lunch.
PRESENTATIONS OF PROJECTS
13:00-15:00
Teams present in front of the expert panel.
BREAK
15:00-15:30
The participants have time for networking while the panel decides on the winning team.
AWARD PRESENTATION AND APERÒ
15:45-18:00
The panel declares the winning team and the award is presented to the winners. The participants and the companys' representatives have time to network at the aperò.
BEGINNING OF THE CASE CHALLENGE
13:45-14:30
Presentation of the challenges and division of participants into balanced teams.
WORK IN TEAMS
14:30-18:00
Teams work in separate seminar rooms.
Speakers
Josefine Reber
Project leader and Lab Head, Novartis Institutes for BioMedical Research, Basel, Switzerland
Sven Rottenberg
Institute of Animal Pathology (Vetsuisse Faculty) and Cancer Therapy Resistance Cluster (DBMR), Bern Center for Precision Medicine, University of Bern, Switzerland
Jean-Christophe Leroux
Professor of Drug Formulation and Delivery and head of the
Institute of Pharmaceutical Sciences at ETH Zurich, Switzerland.
Marieta Duvnjak
Scientific Advisor and Global lead of Innovation Committee in Analytical Research and Development at Novartis, Switzerland
Hanns-Christian Mahler
Chief Enablement Officer (CEO) & Board Member,
ten23 health AG, Basel, Switzerland
EXPERT PANEL
Pierre Mateo
Senior Research Associate at the University of Bern, Switzerland
Carlita Girardin-van der Klaauw
Country Medical Director Glaxo Smith Kline, Switzerland
Stefanie Dobitz
Innovation & Startup Advisor for Health, Medicine, and Life Sciences at the University of Bern and Inselspital
Theresa Visarius
Vice President of Business Development at Immunophotonics and Managing Director of IPS Biopharma AG
Jean-Louis Reymond
Professor of Chemistry at the University of Bern, Switzerland
Karmen Letonja
Head Medical Affairs specialty and respiratory Glaxo Smith Kline, Switzerland
Dr Josefine Reber
Project leader and Lab Head, Novartis Institutes for BioMedical Research, Basel, Switzerland
Toni Widmer
Senior Technical Expert at Novartis, Basel
Nadine C. Martin
Head of Innovation Management at sitem-insel AG
ORGANISING TEAM
Zarja Peters
Performing Arts Manager
Anastasiia Haisenok
Volunteer
Laurianne Pillet
Marketing Manager
Garima Yadav
Volunteer